Concepedia

Publication | Open Access

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial

136

Citations

19

References

2008

Year

Abstract

Among patients with advanced renal cell carcinoma receiving sorafenib treatment, outcomes of older (>or=70 years) and younger (<70 years) patients were similar.

References

YearCitations

Page 1